AstraZeneca faced resistance from some shareholders last year who voted against proposals to change its executive pay policy, which could have seen the chief executive earn as much as £18.7 million last year.
“Despite an increasingly volatile environment globally, Mr Soriot has led AstraZeneca to deliver strong results in 2024, with another year of robust top line growth and impressive results from the pipeline,” the company said.
The boss of drugmaker AstraZeneca was handed a pay package worth nearly £15 million last year, new company accounts reveal.
A spokesman for AstraZeneca said on the latest payout: “The remuneration of our executive directors and our wider workforce reflects the underlying performance of the company, which has generated a total shareholder return of 33% over the past three years.”.
The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024.
.jpeg?trim=312,0,313,0&quality=75&auto=webp&width=1000)
